Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans

Area of Science:

• Immunology
• Virology
• Cell Biology

Background:

• CD8+ lymphocytes play a crucial role in host defense against HIV-1.
• HIV-1 replication is inhibited by CD8+ lymphocytes via cytolytic and non-cytolytic pathways.

Purpose of the Study:

• To investigate the localization and co-secretion of cytolytic and chemokine mediators by HIV-1-specific CD8+ cytotoxic T lymphocytes (CTL).
• To understand the functional significance of these mediators in controlling HIV-1 infection.

Main Methods:

• Used granzyme A as a marker for cytolytic granule proteins.
• Utilized macrophage inflammatory protein (MIP)-1alpha and RANTES as markers for HIV-1 inhibitory chemokines.
• Analyzed the secretion of these mediators following antigen-specific activation of CTLs.

Main Results:

• Both cytolytic (granzyme A) and non-cytolytic (MIP-1alpha, RANTES) mediators are localized within the cytolytic granules of HIV-1-specific CTLs.
• These mediators are co-secreted upon antigen-specific activation, contributing to both cell lysis and free virus inhibition.
• RANTES, MIP-1alpha, and MIP-1beta are secreted as a complex with sulphated proteoglycans, with heparan sulphate enhancing RANTES's inhibition of HIV-1 infection in monocytes.

Conclusions:

• HIV-1-specific CTLs employ a dual-action mechanism involving co-localized cytolytic and chemokine mediators for effective viral control.
• The co-secretion of these mediators enhances the inhibition of both infected cells and free virus.
• Proteoglycan association with chemokines, particularly heparan sulphate with RANTES, is functionally significant for inhibiting monocyte infection.